Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand… Read more
Sofwave Medical Ltd (SOFW) - Total Assets
Latest total assets as of September 2025: ILA46.96 Million ILA
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) holds total assets worth ILA46.96 Million ILA as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sofwave Medical Ltd - Total Assets Trend (2018–2024)
This chart illustrates how Sofwave Medical Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sofwave Medical Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Sofwave Medical Ltd's total assets of ILA46.96 Million consist of 90.2% current assets and 9.8% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 50.2% |
| Accounts Receivable | ILA10.07 Million | 23.4% |
| Inventory | ILA5.88 Million | 13.7% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Sofwave Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sofwave Medical Ltd's current assets represent 90.2% of total assets in 2024, a decrease from 94.8% in 2018.
- Cash Position: Cash and equivalents constituted 50.2% of total assets in 2024, up from 22.3% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 23.4% of total assets.
Sofwave Medical Ltd Competitors by Total Assets
Key competitors of Sofwave Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Sofwave Medical Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Sofwave Medical Ltd generates 1.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sofwave Medical Ltd is currently not profitable relative to its asset base.
Sofwave Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.37 | 2.43 | 2.05 |
| Quick Ratio | 2.08 | 2.05 | 1.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA24.53 Million | ILA 20.71 Million | ILA 2.31 Million |
Sofwave Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Sofwave Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 14.61 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | ILA43.03 Million |
| Market Capitalization | $3.18 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sofwave Medical Ltd's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Sofwave Medical Ltd's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Sofwave Medical Ltd (2018–2024)
The table below shows the annual total assets of Sofwave Medical Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA43.03 Million | -1.16% |
| 2023-12-31 | ILA43.54 Million | -5.51% |
| 2022-12-31 | ILA46.08 Million | -24.18% |
| 2021-12-31 | ILA60.77 Million | +1160.77% |
| 2020-12-31 | ILA4.82 Million | -22.63% |
| 2019-12-31 | ILA6.23 Million | +950.59% |
| 2018-12-31 | ILA593.00K | -- |